デフォルト表紙
市場調査レポート
商品コード
1224595

静脈内(IV)輸液ポンプの市場規模、シェア、動向分析レポート:製品別(容量性、インスリン、シリンジ、経腸、外来)、疾患適応症別、地域別、セグメント別予測、2023年~2030年

Intravenous Infusion Pump Market Size, Share & Trends Analysis Report By Product (Volumetric, Insulin, Syringe, Enteral, Ambulatory), By Disease Indication, By Region, And Segment Forecasts, 2023 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 100 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.49円
静脈内(IV)輸液ポンプの市場規模、シェア、動向分析レポート:製品別(容量性、インスリン、シリンジ、経腸、外来)、疾患適応症別、地域別、セグメント別予測、2023年~2030年
出版日: 2023年01月13日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

静脈内(IV)輸液ポンプ市場の成長と動向

Grand View Research, Inc.の最新レポートによると、静脈内(IV)輸液ポンプの世界市場規模は2030年までに99億米ドルに達し、2023年から2030年までCAGR8.3%で拡大すると予想されています。特殊ポンプやスマートポンプのイントロダクションと開発が、輸液ポンプ産業の決定的な成長の原因となっています。スマート輸液ポンプは、エラー削減ソフトウェアとカスタマイズされた薬剤ライブラリが組み込まれているため、市場に弾みをつける進歩だと考えられています。2018年にMindray Medical社が実施した調査によると、輸液ポンプは最も従来の病院のレンタル機器です。

心血管やがんなどの疾患の増加は、静脈内(IV)輸液ポンプ装置の需要を促進し続けています。静脈内(IV)輸液ポンプは、薬物や栄養素の調節された、制御された、そしてエラーのない送達を保証します。このようなプロセスは、化学療法や放射線療法で患者を治療する際に不可欠です。これらは非常に複雑なプロセスであり、薬物の非常に正確な投与量を必要とします。点滴ポンプ装置の技術革新、自動化、標準化された投与などの要因の融合は、患者にとって治療をより便利でユーザーフレンドリーにすると予想されます。

静脈内(IV)輸液ポンプ業界は、COVID-19の大流行により、2020年に需要の伸びを示しました。これは、輸液ポンプが健康上の緊急事態に使用される最も一般的な医療機器であるためです。パンデミックにより、使用量の増加でヘルスケア施設に負担がかかると、輸液ポンプのような医療機器の需要が大きく急増しました。2020年5月、FDAは輸液ポンプと輸液ポンプ付属品の緊急使用に関する包括的な認可も発行しました。このようなヘルスケアプロバイダーによる使用の増加は、輸液ポンプの需要の増加に対応しました。

静脈内(IV)輸液ポンプ市場レポートハイライト

緊急時や化学療法などの治療時に、栄養剤や薬物などの送達流体の使用が増加していることから、体積式輸液ポンプが2022年に最大の製品セグメントとして浮上した

インスリン注入ポンプは、糖尿病の負担が世界的に増加していることから、予測期間中に最も高いCAGRを記録すると予測される

最適なケアと栄養を必要とする早産が増加しているため、小児科/新生児科分野が2022年の疾患適応の点で市場を独占

アジア太平洋地域は、老人や糖尿病患者の増加により、予測期間中に最も急速な成長を遂げると予測

目次

第1章 調査手法と範囲

  • 市場セグメンテーションと範囲
    • 製品
    • 適応疾患
    • 地域範囲
  • 調査手法
  • 情報調達
    • 購入したデータベース
    • GVRの内部データベース
    • 二次情報
    • 1次調査
  • 情報またはデータ分析
    • データ分析モデル
  • 市場の策定と検証
  • モデルの詳細
    • コモディティフロー分析(モデル1)
    • ボリューム価格分析(モデル2)
  • 二次情報一覧
  • 一次情報のリスト
  • 目的

第2章 エグゼクティブサマリー

  • 市場の見通し
  • セグメントの見通し
  • 競合考察

第3章 静脈内(IV)輸液ポンプ市場の変数、動向、範囲

  • 市場系列の見通し
    • 親市場の見通し
    • 関連/補助的な市場の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
    • 業界の課題
  • 点滴ポンプ:市場分析ツール
    • 業界分析- ポーターズ
    • PESTEL分析
    • 主要取引と戦略的提携分析
    • COVID-19影響分析

第4章 静脈内(IV)輸液ポンプ市場:セグメント分析、製品別、2018年から2030年(百万米ドル)

  • 定義と範囲
  • 製品市場シェア分析、2018年および2030年
  • セグメントダッシュボード
  • 世界の点滴ポンプ市場、製品別、2022年から2030年
  • 2018年から2030年までの以下の市場規模と予測、トレンド分析
    • 製品別
      • 容積式輸液ポンプ
      • インスリン注入ポンプ
      • シリンジ輸液ポンプ
      • 経腸輸液ポンプ
      • 携帯型輸液ポンプ
      • 患者管理鎮痛(PCA)
      • 埋め込み型輸液ポンプ
      • その他

第5章 静脈内(IV)輸液ポンプ市場:セグメント分析、疾患適応別、2018年から2030年(百万米ドル)

  • 定義と範囲
  • 疾患適応症の市場シェア分析、2022年および2030年
  • セグメントダッシュボード
  • 2018年から2030年までの疾患適応症別の世界の静脈内(IV)輸液ポンプ市場
  • 2018年から2030年までの以下の市場規模と予測、トレンド分析
    • 化学療法
    • 糖尿病
    • 消化器科
    • 鎮痛・疼痛管理
    • 小児科・新生児科
    • 血液学
    • その他

第6章 静脈内(IV)輸液ポンプ市場:地域市場分析、製品別、2018年から2030年(百万米ドル)

  • 定義と範囲
  • 地域市場シェア分析、2022年および2030年
  • 地域市場ダッシュボード
  • 地域市場のスナップショット
  • 地域市場シェア、2022年
  • 市場規模、予測、トレンド分析、2018年から2030年:
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • オランダ
    • ベルギー
    • スイス
    • ロシア
    • スウェーデン
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • マレーシア
    • インドネシア
    • シンガポール
    • フィリピン
    • タイ
    • ニュージーランド
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • チリ
  • 中東とアフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • エジプト

第7章 静脈内(IV)輸液ポンプ市場-競合分析

  • 主要な市場参入企業別最近の動向と影響分析
  • 企業/競合の分類(主要なイノベーター、マーケットリーダー、新興企業)
    • 参入企業
    • イノベーター
  • ベンダー情勢
    • 主要サービスプロバイダーのリスト
      • 市場の差別化要因
      • 点滴ポンプ-市場シェア分析
  • 主な企業紹介
    • Baxter International
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • B. Braun Melsungen AG
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Medtronic
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Micrel Medical Devices Sa
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Fresenius Kabi
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Boston Scientific Corporation
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • CAREFUSION CORPORATION
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Smiths Medical
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • F. Hoffmann-La Roche Ltd.
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Tandem Diabetes Care, Inc.
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Terumo Corporation
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Mindray
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Moog Inc.
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • IRadimed Corporation
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Intravenous Infusion Pumps Market, By Region 2018 - 2030 (USD Million)
  • Table 4 Global Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 5 Global Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 6 North America Intravenous Infusion Pumps Market, By Country, 2018 - 2030 (USD Million)
  • Table 7 North America Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 8 North America Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 9 U.S. Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 10 U.S. Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 11 Canada Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 12 Canada Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 13 Europe Intravenous Infusion Pumps Market, By Country, 2018 - 2030 (USD Million)
  • Table 14 Europe Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 15 Europe Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 16 U.K. Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 17 U.K. Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 18 Germany Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 19 Germany Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 20 France Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 21 France Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 22 Italy Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 23 Italy Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 24 Spain Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 25 Spain Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 26 Netherlands Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 27 Netherlands Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 28 Belgium Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 29 Belgium Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 30 Switzerland Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 31 Switzerland Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 32 Russia Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 33 Russia Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 34 Sweden Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 35 Sweden Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 36 Asia Pacific Intravenous Infusion Pumps Market, By Country, 2018 - 2030 (USD Million)
  • Table 37 Asia Pacific Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 38 Asia Pacific Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 39 India Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 40 India Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 41 Japan Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 42 Japan Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 43 China Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 44 China Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 45 Australia Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 46 Australia Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 47 South Korea Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 48 South Korea Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 49 Malaysia Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 50 Malaysia Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 51 Indonesia Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 52 Indonesia Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 53 Singapore Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 54 Singapore Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 55 Philippines Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 56 Philippines Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 57 Thailand Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 58 Thailand Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 59 Thailand Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 60 Thailand Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 61 Latin America Intravenous Infusion Pumps Market, By Country, 2018 - 2030 (USD Million)
  • Table 62 Latin America Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 63 Latin America Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 64 Brazil Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 65 Brazil Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 66 Mexico Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 67 Mexico Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 68 Argentina Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 69 Argentina Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 70 Colombia Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 71 Colombia Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 72 Chile Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 73 Chile Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 74 MEA Intravenous Infusion Pumps Market, By Country, 2018 - 2030 (USD Million)
  • Table 75 MEA Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 76 MEA Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 77 South Africa Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 78 South Africa Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 79 Saudi Arabia Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 80 Saudi Arabia Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 81 UAE Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 82 UAE Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 83 Israel Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 84 Israel Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 85 Egypt Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 86 Egypt Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Intravenous Infusion Pumps Market: Market snapshot
  • Fig. 8 Intravenous Infusion Pumps Market: Market segmentation
  • Fig. 9 Intravenous Infusion Pumps Market Strategy Framework
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Intravenous Infusion Pumps Market driver impact
  • Fig. 13 Intravenous Infusion Pumps Market restraint impact
  • Fig. 14 Intravenous Infusion Pumps Market Porter's Five Forces Analysis
  • Fig. 15 Intravenous Infusion Pumps Market PESTEL analysis
  • Fig. 16 Intravenous Infusion Pumps Market segment dashboard
  • Fig. 17 Intravenous Infusion Pumps Market: Product Movement Analysis
  • Fig. 18 Infusion pumps estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Intravenous Sets estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 IV cannulas estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Volumetric Infusion Pumps estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Insulin Infusion Pumps Market segment dashboard
  • Fig. 23 Intravenous Infusion Pumps Market: Disease Indication Movement Analysis
  • Fig. 24 Chemotherapy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Endocrinology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Diabetes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Gastroenterology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Analgesia/ Pain management market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Pediatrics/neonatology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Hematology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Global Intravenous Infusion Pumps Market: Regional movement analysis
  • Fig. 33 Global Intravenous Infusion Pumps Market: Regional outlook and key takeaways
  • Fig. 34 Global market share, by region
  • Fig. 35 North America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Netherlands market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Belgium market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Switzerland market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Russia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 China market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Malaysia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Indonesia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Singapore market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Philippines market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Colombia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Chile market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Middle East and Africa. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 Israel market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 Egypt market estimates and forecast, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68038-560-1

Intravenous Infusion Pump Market Growth & Trends:

The global intravenous infusion pump market size is expected to reach USD 9.9 billion by 2030 and is expected to expand at 8.3% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. The introduction and development of specialty and smart pumps are responsible for the crucial growth of the infusion pump industry. Smart infusion pumps are considered an advancement that will give a boost to the market as it embeds error-reduction software and customized drug libraries. According to a study conducted by Mindray Medical company in 2018, infusion pumps are the most conventional hospital rental equipment.

The rise in diseases like cardiovascular and cancer continues to drive the demand for intravenous infusion pump devices. Intravenous infusion pumps ensure regulated, controlled, and error-free delivery of medications and nutrients. Such processes are essential while treating patients via chemotherapy or radiation therapy. These are very complex processes and require a very precise dosage of medication. The amalgamation of factors like shift in technology, automation, and standardized dosing for intravenous pump devices are anticipated to make therapy more convenient and user-friendly for patients.

The intravenous infusion pumps industry witnessed growth in demand in 2020 due to the COVID-19 pandemic. This was because infusion pumps are the most common medical devices used in health emergencies. As the pandemic burdened healthcare facilities due to increased use, the demand for medical devices like infusion pumps witnessed a major surge. In May 2020, the FDA also issued an umbrella authorization for the emergency use of infusion pumps and infusion pump accessories. This increased use by healthcare providers catered to the increased demand for infusion pumps.

Intravenous Infusion Pump Market Report Highlights:

  • Volumetric infusion pumps emerged as the largest product segment in 2022, owing to the increasing use of delivery fluids such as nutrients and medications during emergencies and treatments like chemotherapy
  • The insulin infusion pumps segment is projected to register the highest CAGR over the forecast period as the burden of diabetes increases globally
  • The pediatrics/ neonatology segment dominated the market in 2022 in terms of disease indication as there have been growing incidences of premature births, which require optimum care and nutrition
  • The Asia Pacific market is projected to witness the fastest growth over the forecast period owing to the increasing number of geriatric and diabetic patients in the region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Disease Indication
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Volume price analysis (Model 2)
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Intravenous Infusion Pumps Market Variables, Trends & Scope

  • 3.1. Market Lineage outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
    • 3.2.3. Industry Challenges
  • 3.3. Intravenous Infusion Pumps: Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. Major Deals & Strategic Alliances Analysis
    • 3.3.4. COVID-19 Impact Analysis

Chapter 4. Intravenous Infusion Pumps Market: Segment Analysis, by Product, 2018 - 2030 (USD Million)

  • 4.1. Definitions & Scope
  • 4.2. Product market share analysis, 2018 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Intravenous Infusion Pumps Market, by Product, 2022 to 2030
  • 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. By product
      • 4.5.1.1. Volumetric Infusion pumps
      • 4.5.1.2. Insulin Infusion pumps
      • 4.5.1.3. Syringe Infusion pumps
      • 4.5.1.4. Enteral Infusion pumps
      • 4.5.1.5. Ambulatory Infusion pumps
      • 4.5.1.6. Patient Controlled Analgesia (PCA)
      • 4.5.1.7. Implantable Infusion pumps
      • 4.5.1.8. Others

Chapter 5. Intravenous Infusion Pumps Market: Segment Analysis, By Disease Indication, 2018 - 2030 (USD Million)

  • 5.1. Definitions & Scope
  • 5.2. Disease Indication market share analysis, 2022 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Global Intravenous Infusion Pumps Market, By Disease Indication, 2018 to 2030
  • 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.5.1. Chemotherapy
    • 5.5.2. Diabetes
    • 5.5.3. Gastroenterology
    • 5.5.4. Analgesia/Pain Management
    • 5.5.5. Pediatrics/Neonatology
    • 5.5.6. Hematology
    • 5.5.7. Others

Chapter 6. Intravenous Infusion Pumps Market: Regional Market Analysis, by Product, 2018 - 2030 (USD Million)

  • 6.1. Definitions & Scope
  • 6.2. Regional Market Share Analysis, 2022 & 2030
  • 6.3. Regional Market Dashboard
  • 6.4. Regional Market Snapshot
  • 6.5. Regional Market Share, 2022
  • 6.6. Market Size, & Forecasts, and Trend Analysis, 2018 to 2030:
  • 6.7. North America
    • 6.7.1. Market estimates and forecast, by country, 2018 - 2030 (USD Million)
    • 6.7.2. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
    • 6.7.3. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.7.4. U.S.
      • 6.7.4.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.7.4.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.7.5. Canada
      • 6.7.5.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.7.5.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
  • 6.8. Europe
    • 6.8.1. Market estimates and forecast, by country, 2018 - 2030 (USD Million)
    • 6.8.2. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
    • 6.8.3. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.8.4. Germany
      • 6.8.4.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.8.4.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.8.5. U.K.
      • 6.8.5.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.8.5.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.8.6. France
      • 6.8.6.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.8.6.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.8.7. Italy
      • 6.8.7.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.8.7.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.8.8. Spain
      • 6.8.8.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.8.8.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.8.9. Netherlands
      • 6.8.9.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.8.9.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.8.10. Belgium
      • 6.8.10.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.8.10.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.8.11. Switzerland
      • 6.8.11.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.8.11.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.8.12. Russia
      • 6.8.12.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.8.12.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.8.13. Sweden
      • 6.8.13.1 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.8.13.2 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
  • 6.9. Asia Pacific
    • 6.9.1. Market estimates and forecast, by country, 2018 - 2030 (USD Million)
    • 6.9.2. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
    • 6.9.3. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.9.4. China
      • 6.9.4.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.9.4.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.9.5. Japan
      • 6.9.5.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.9.5.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.9.6. India
      • 6.9.6.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.9.6.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.9.7. Australia
      • 6.9.7.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.9.7.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.9.8. South Korea
      • 6.9.8.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.9.8.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.9.9. Malaysia
      • 6.9.9.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.9.9.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.9.10. Indonesia
      • 6.9.10.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.9.10.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.9.11 Singapore
      • 6.9.11.1 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.9.11.2 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.9.12 Philippines
      • 6.9.12.1 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.9.12.2 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.9.13 Thailand
      • 6.9.13.1 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.9.13.2 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.9.14 New Zealand
      • 6.9.14.1 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.9.14.2 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
  • 6.10 Latin America
    • 6.10.1 Market estimates and forecast, by country, 2018 - 2030 (USD Million)
    • 6.10.2 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
    • 6.10.3 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.10.4 Brazil
      • 6.10.4.1 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.10.4.2 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.10.5 Mexico
      • 6.10.5.1 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.10.5.2 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.10.6 Argentina
      • 6.10.6.1 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.10.6.2 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.10.7 Colombia
      • 6.10.7.1 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.10.7.2 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.10.8 Chile
      • 6.10.8.1 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.10.8.2 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
  • 6.11 Middle East and Africa
    • 6.11.1 Market estimates and forecast, by country, 2018 - 2030 (USD Million)
    • 6.11.2 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
    • 6.11.3 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.11.4 South Africa
      • 6.11.4.1 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.11.4.2 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.11.5 Saudi Arabia
      • 6.11.5.1 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.11.5.2 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.11.6 UAE
      • 6.11.6.1 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.11.6.2 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.11.7 Israel
      • 6.11.7.1 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.11.7.2 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.11.8 Egypt
      • 6.11.8.1 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.11.8.2 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)

Chapter 7 Intravenous Infusion Pumps Market - Competitive Analysis

  • 7.1 Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2 Company/Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
    • 7.2.1 Participant Categorization
    • 7.2.2 Innovators
  • 7.3 Vendor Landscape
    • 7.3.1 List of Key Service Providers
      • 7.3.1.1 Market Differentiators
      • 7.3.1.2 Intravenous Infusion Pumps- Market Share Analysis
  • 7.4 Key companies profiled
    • 7.4.1 Baxter International
      • 7.4.1.1 Company Overview
      • 7.4.1.2 Financial Performance
      • 7.4.1.3 Product Benchmarking
      • 7.4.1.4 Strategic Initiatives
    • 7.4.2 B. Braun Melsungen AG
      • 7.4.2.1 Company Overview
      • 7.4.2.2 Financial Performance
      • 7.4.2.3 Product Benchmarking
      • 7.4.2.4 Strategic Initiatives
    • 7.4.3 Medtronic
      • 7.4.3.1 Company Overview
      • 7.4.3.2 Financial Performance
      • 7.4.3.3 Product Benchmarking
      • 7.4.3.4 Strategic Initiatives
    • 7.4.4 Micrel Medical Devices Sa
      • 7.4.4.1 Company Overview
      • 7.4.4.2 Financial Performance
      • 7.4.4.3 Product Benchmarking
      • 7.4.4.4 Strategic Initiatives
    • 7.4.5 Fresenius Kabi
      • 7.4.5.1 Company Overview
      • 7.4.5.2 Financial Performance
      • 7.4.5.3 Product Benchmarking
      • 7.4.5.4 Strategic Initiatives
    • 7.4.6 Boston Scientific Corporation
      • 7.4.6.1 Company Overview
      • 7.4.6.2 Financial Performance
      • 7.4.6.3 Product Benchmarking
      • 7.4.6.4 Strategic Initiatives
    • 7.4.7 CAREFUSION CORPORATION
      • 7.4.7.1 Company Overview
      • 7.4.7.2 Financial Performance
      • 7.4.7.3 Product Benchmarking
      • 7.4.7.4 Strategic Initiatives
    • 7.4.8 Smiths Medical
      • 7.4.8.1 Company Overview
      • 7.4.8.2 Financial Performance
      • 7.4.8.3 Product Benchmarking
      • 7.4.8.4 Strategic Initiatives
    • 7.4.9 F. Hoffmann-La Roche Ltd.
      • 7.4.9.1 Company Overview
      • 7.4.9.2 Financial Performance
      • 7.4.9.3 Product Benchmarking
      • 7.4.9.4 Strategic Initiatives
    • 7.4.10 Tandem Diabetes Care, Inc.
      • 7.4.10.1 Company Overview
      • 7.4.10.2 Financial Performance
      • 7.4.10.3 Product Benchmarking
      • 7.4.10.4 Strategic Initiatives
    • 7.4.11 Terumo Corporation
      • 7.4.11.1 Company Overview
      • 7.4.11.2 Financial Performance
      • 7.4.11.3 Product Benchmarking
      • 7.4.11.4 Strategic Initiatives
    • 7.4.12 Mindray
      • 7.4.12.1 Company Overview
      • 7.4.12.2 Financial Performance
      • 7.4.12.3 Product Benchmarking
      • 7.4.12.4 Strategic Initiatives
    • 7.4.13 Moog Inc.
      • 7.4.13.1 Company Overview
      • 7.4.13.2 Financial Performance
      • 7.4.13.3 Product Benchmarking
      • 7.4.13.4 Strategic Initiatives
    • 7.4.14 IRadimed Corporation
      • 7.4.14.1 Company Overview
      • 7.4.14.2 Financial Performance
      • 7.4.14.3 Product Benchmarking
      • 7.4.14.4 Strategic Initiatives